TM-5441 is a plasminogen activator inhibitor-1 (PAI-1) which shows inhibitory effect on several tumor cell lines with IC50 of 9.7 μM- 60.3 μM.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | TM5441 is an orally bioavailable PAI-1 inhibitor with an IC50 ranging from 13.9 to 51.1 μM, capable of inducing intrinsic apoptosis in various human cancer cell lines. TM5441 can alleviate cardiac hypertension and vascular senescence induced by Nω-nitro-l-arginine methyl ester[1][2]. TM5441 inhibits the proliferation of HT1080, HCT116, Daoy, MDA-MB-231, and Jurkat cells in a dose-dependent manner, with IC50 values ranging from 13.9 to 51.1 μM. It also dose-dependently increases caspase 3/7 activity in HT1080 and HCT116 cells. Furthermore, TM5441 enhances apoptosis in these cells and induces mitochondrial depolarization[1]. In mouse proximal tubular epithelial cells, TM5441 effectively inhibits the fibrosis and inflammatory marker mRNA expression induced by PAI-1, and reverses the inhibition of plasminogen activator activity induced by PAI-1[2]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.33mL 0.47mL 0.23mL |
11.66mL 2.33mL 1.17mL |
23.32mL 4.66mL 2.33mL |
CAS号 | 1190221-43-2 |
分子式 | C21H17ClN2O6 |
分子量 | 428.82 |
SMILES Code | O=C(O)C1=CC(Cl)=CC=C1NC(COCC(NC2=CC=CC(C3=COC=C3)=C2)=O)=O |
MDL No. | MFCD31382187 |
别名 | |
运输 | 蓝冰 |
InChI Key | BGGMLMAPVODXAU-UHFFFAOYSA-N |
Pubchem ID | 44250349 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Inert atmosphere, store in freezer, under -20°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|